Veracyte Inc (NASDAQ: VCYT) kicked off on Monday, up 3.30% from the previous trading day, before settling in for the closing price of $33.03. Over the past 52 weeks, VCYT has traded in a range of $18.61-$35.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 34.42% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 115.19%. With a float of $75.65 million, this company’s outstanding shares have now reached $76.81 million.
In an organization with 815 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.56%, operating margin of -8.18%, and the pretax margin is -13.71%.
Veracyte Inc (VCYT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Veracyte Inc is 1.51%, while institutional ownership is 104.08%. The most recent insider transaction that took place on Sep 19 ’24, was worth 182,263. In this transaction Director of this company sold 5,173 shares at a rate of $35.23, taking the stock ownership to the 0 shares. Before that another transaction happened on Sep 04 ’24, when Company’s Chief Commercial Officer-CLIA sold 5,479 for $29.78, making the entire transaction worth $163,159. This insider now owns 76,174 shares in total.
Veracyte Inc (VCYT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.41 earnings per share (EPS), lower than consensus estimate (set at -0.15) by -0.26. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 115.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.00% during the next five years compared to -10.52% drop over the previous five years of trading.
Veracyte Inc (NASDAQ: VCYT) Trading Performance Indicators
Take a look at Veracyte Inc’s (VCYT) current performance indicators. Last quarter, stock had a quick ratio of 4.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.56. Likewise, its price to free cash flow for the trailing twelve months is 65.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.37 in one year’s time.
Technical Analysis of Veracyte Inc (VCYT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.58 million. That was inferior than the volume of 0.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.86%. Additionally, its Average True Range was 1.14.
During the past 100 days, Veracyte Inc’s (VCYT) raw stochastic average was set at 91.19%, which indicates a significant increase from 72.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.58% in the past 14 days, which was lower than the 58.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.62, while its 200-day Moving Average is $25.32. However, in the short run, Veracyte Inc’s stock first resistance to watch stands at $34.61. Second resistance stands at $35.10. The third major resistance level sits at $35.84. If the price goes on to break the first support level at $33.38, it is likely to go to the next support level at $32.64. Assuming the price breaks the second support level, the third support level stands at $32.15.
Veracyte Inc (NASDAQ: VCYT) Key Stats
The company with the Market Capitalisation of 2.62 billion has total of 76,448K Shares Outstanding. Its annual sales at the moment are 361,050 K in contrast with the sum of -74,400 K annual income. Company’s last quarter sales were recorded 114,430 K and last quarter income was 5,730 K.
